Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionATP-dependent activity

SMARCA4 PSMC4 UBA3 CHD1L MSH3 KIF5C IQCA1

1.64e-04614397GO:0140657
GeneOntologyMolecularFunctionvinculin binding

DMD UTRN

2.86e-0413392GO:0017166
GeneOntologyMolecularFunctionDNA polymerase binding

SMARCA4 SMG6

9.16e-0423392GO:0070182
GeneOntologyMolecularFunctionRNA polymerase II-specific DNA-binding transcription factor binding

SMARCA4 MLXIPL UBA3 SPEN THRAP3

1.24e-03417395GO:0061629
GeneOntologyMolecularFunctionATP hydrolysis activity

SMARCA4 PSMC4 CHD1L KIF5C IQCA1

1.59e-03441395GO:0016887
GeneOntologyMolecularFunctionATP-dependent activity, acting on DNA

SMARCA4 CHD1L MSH3

1.94e-03127393GO:0008094
GeneOntologyBiologicalProcessestablishment of meiotic spindle localization

SPIRE1 SPATA17

4.68e-056372GO:0051295
GeneOntologyBiologicalProcessnuclear-transcribed mRNA catabolic process

ATM EIF4ENIF1 THRAP3 SMG6

8.99e-05132374GO:0000956
GeneOntologyBiologicalProcessnegative regulation of telomere capping

ATM SMG6

1.12e-049372GO:1904354
GeneOntologyBiologicalProcesshexose mediated signaling

SMARCA4 MLXIPL

1.70e-0411372GO:0009757
GeneOntologyBiologicalProcessglucose mediated signaling pathway

SMARCA4 MLXIPL

1.70e-0411372GO:0010255
GeneOntologyBiologicalProcesssugar mediated signaling pathway

SMARCA4 MLXIPL

1.70e-0411372GO:0010182
GeneOntologyBiologicalProcessestablishment of spindle localization

SPIRE1 SPATA17 ENKD1

1.87e-0462373GO:0051293
GeneOntologyBiologicalProcessorganelle localization

SPIRE1 SPATA17 ATM KIF5C DMD ENKD1 MAD1L1

2.19e-04703377GO:0051640
GeneOntologyBiologicalProcessspindle localization

SPIRE1 SPATA17 ENKD1

2.35e-0467373GO:0051653
GeneOntologyBiologicalProcesscarbohydrate mediated signaling

SMARCA4 MLXIPL

2.41e-0413372GO:0009756
GeneOntologyBiologicalProcessestablishment of organelle localization

SPIRE1 SPATA17 ATM KIF5C ENKD1 MAD1L1

3.87e-04546376GO:0051656
DomainNPIP

NPIPB3 NPIPB5 NPIPB13

3.51e-0614413IPR009443
DomainDystrophin

DMD UTRN

4.70e-062412IPR016344
DomainSPOC_met

RBM15 SPEN

1.41e-053412IPR010912
DomainSPOC

RBM15 SPEN

2.81e-054412PS50917
Domain-

RBM15 SPEN

4.68e-0554122.40.290.10
DomainSPOC-like_C_dom

RBM15 SPEN

4.68e-055412IPR016194
DomainEF-hand_dom_typ1

DMD UTRN

7.01e-056412IPR015153
DomainEF-hand_dom_typ2

DMD UTRN

7.01e-056412IPR015154
DomainEF-hand_2

DMD UTRN

7.01e-056412PF09068
DomainEF-hand_3

DMD UTRN

7.01e-056412PF09069
DomainSPOC

RBM15 SPEN

7.01e-056412PF07744
DomainSPOC_C

RBM15 SPEN

7.01e-056412IPR012921
DomainZF_ZZ_2

DMD UTRN

7.04e-0418412PS50135
DomainZF_ZZ_1

DMD UTRN

7.04e-0418412PS01357
DomainZZ

DMD UTRN

7.04e-0418412PF00569
DomainZnf_ZZ

DMD UTRN

7.85e-0419412IPR000433
DomainZnF_ZZ

DMD UTRN

7.85e-0419412SM00291
DomainActinin_actin-bd_CS

DMD UTRN

1.16e-0323412IPR001589
DomainACTININ_2

DMD UTRN

1.16e-0323412PS00020
DomainACTININ_1

DMD UTRN

1.16e-0323412PS00019
DomainSpectrin

DMD UTRN

1.16e-0323412PF00435
DomainSpectrin_repeat

DMD UTRN

1.84e-0329412IPR002017
DomainSNF2_N

SMARCA4 CHD1L

2.24e-0332412PF00176
DomainSNF2_N

SMARCA4 CHD1L

2.24e-0332412IPR000330
DomainSpectrin/alpha-actinin

DMD UTRN

2.24e-0332412IPR018159
DomainSPEC

DMD UTRN

2.24e-0332412SM00150
DomainP-loop_NTPase

SMARCA4 PSMC4 CHD1L MSH3 SPATA17 KIF5C IQCA1

2.26e-03848417IPR027417
DomainAAA

PSMC4 IQCA1

2.52e-0334412PS00674
DomainWW

DMD UTRN

4.77e-0347412PF00397
DomainWW

DMD UTRN

4.98e-0348412SM00456
DomainWW_DOMAIN_2

DMD UTRN

5.60e-0351412PS50020
DomainWW_DOMAIN_1

DMD UTRN

5.60e-0351412PS01159
DomainSMAD_FHA_domain

FHAD1 IRF3

5.82e-0352412IPR008984
DomainWW_dom

DMD UTRN

5.82e-0352412IPR001202
DomainAAA

PSMC4 IQCA1

5.82e-0352412PF00004
DomainATPase_AAA_core

PSMC4 IQCA1

6.26e-0354412IPR003959
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

PDXDC1 RBM15 ATM DMD SPEN UTRN THRAP3

1.29e-0731344738270169
Pubmed

Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.

DMD UTRN

1.56e-06244210525423
Pubmed

Distribution of dystrophin- and utrophin-associated protein complexes during activation of human neutrophils.

DMD UTRN

1.56e-06244220434517
Pubmed

Plasma lipidomic analysis shows a disease progression signature in mdx mice.

DMD UTRN

1.56e-06244234155298
Pubmed

In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.

DMD UTRN

1.56e-06244228790199
Pubmed

Dystrophic changes in extraocular muscles after gamma irradiation in mdx:utrophin(+/-) mice.

DMD UTRN

1.56e-06244224466085
Pubmed

The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy.

DMD UTRN

1.56e-06244227110493
Pubmed

Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice.

DMD UTRN

1.56e-06244224781208
Pubmed

Isolation and characterization of a genomic clone from the murine utrophin locus.

DMD UTRN

1.56e-0624428268660
Pubmed

Metabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophy.

DMD UTRN

1.56e-06244225859846
Pubmed

G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain.

DMD UTRN

1.56e-0624427731967
Pubmed

Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.

DMD UTRN

1.56e-06244227037492
Pubmed

Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue.

DMD UTRN

1.56e-06244216710609
Pubmed

Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.

DMD UTRN

1.56e-06244216487708
Pubmed

Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results.

DMD UTRN

1.56e-06244230672725
Pubmed

Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart.

DMD UTRN

1.56e-06244221677768
Pubmed

Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis.

DMD UTRN

1.56e-0624427962191
Pubmed

Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse.

DMD UTRN

1.56e-0624429713852
Pubmed

Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.

DMD UTRN

1.56e-06244225607927
Pubmed

Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency?

DMD UTRN

1.56e-0624428021701
Pubmed

Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.

DMD UTRN

1.56e-06244226974331
Pubmed

Developmental studies of dystrophin-positive fibers in mdx, and DRP localization.

DMD UTRN

1.56e-0624428433092
Pubmed

Second-generation compound for the modulation of utrophin in the therapy of DMD.

DMD UTRN

1.56e-06244225935002
Pubmed

Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.

DMD UTRN

1.56e-06244216024571
Pubmed

Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.

DMD UTRN

1.56e-06244228453658
Pubmed

A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin.

DMD UTRN

1.56e-06244211801396
Pubmed

Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines.

DMD UTRN

1.56e-0624427987307
Pubmed

Utility of dystrophin and utrophin staining in childhood muscular dystrophy.

DMD UTRN

1.56e-06244216295426
Pubmed

Comparative analysis of the human dystrophin and utrophin gene structures.

DMD UTRN

1.56e-06244211861579
Pubmed

Distinct mechanical properties in homologous spectrin-like repeats of utrophin.

DMD UTRN

1.56e-06244230914715
Pubmed

Dystrophin is a microtubule-associated protein.

DMD UTRN

1.56e-06244219651889
Pubmed

Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.

DMD UTRN

1.56e-0624429590295
Pubmed

Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.

DMD UTRN

1.56e-06244222284942
Pubmed

Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.

DMD UTRN

1.56e-06244229879154
Pubmed

Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.

DMD UTRN

1.56e-06244217889902
Pubmed

Identification of Dp71 isoforms in the platelet membrane cytoskeleton. Potential role in thrombin-mediated platelet adhesion.

DMD UTRN

1.56e-06244212370193
Pubmed

Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models.

DMD UTRN

1.56e-06244232025735
Pubmed

Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice.

DMD UTRN

1.56e-06244227836895
Pubmed

BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.

DMD UTRN

1.56e-06244227750047
Pubmed

Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression.

DMD UTRN

1.56e-06244217967782
Pubmed

Diaphragm rescue alone prevents heart dysfunction in dystrophic mice.

DMD UTRN

1.56e-06244221062902
Pubmed

Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression.

DMD UTRN

1.56e-06244235557546
Pubmed

Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice.

DMD UTRN

1.56e-06244237626761
Pubmed

Molecular heterogeneity of the dystrophin-associated protein complex in the mouse kidney nephron: differential alterations in the absence of utrophin and dystrophin.

DMD UTRN

1.56e-06244215565469
Pubmed

The N- and C-Terminal Domains Differentially Contribute to the Structure and Function of Dystrophin and Utrophin Tandem Calponin-Homology Domains.

DMD UTRN

1.56e-06244226516677
Pubmed

Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging.

DMD UTRN

1.56e-06244222209498
Pubmed

A Protocol for Simultaneous In Vivo Imaging of Cardiac and Neuroinflammation in Dystrophin-Deficient MDX Mice Using [18F]FEPPA PET.

DMD UTRN

1.56e-06244237108685
Pubmed

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.

DMD UTRN

1.56e-06244210694796
Pubmed

Dystrophin and dystrophin-related protein in the central nervous system of normal controls and Duchenne muscular dystrophy.

DMD UTRN

1.56e-0624428171962
Pubmed

Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice.

DMD UTRN

1.56e-06244227822449
Pubmed

Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model.

DMD UTRN

1.56e-06244233651713
Pubmed

Thermodynamic stability, unfolding kinetics, and aggregation of the N-terminal actin-binding domains of utrophin and dystrophin.

DMD UTRN

1.56e-06244222275054
Pubmed

NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation.

DMD UTRN

1.56e-06244227798264
Pubmed

Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice.

DMD UTRN

1.56e-06244231506484
Pubmed

Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.

DMD UTRN

1.56e-0624429288752
Pubmed

Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy.

DMD UTRN

1.56e-0624429288751
Pubmed

Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart.

DMD UTRN

1.56e-06244224337461
Pubmed

Combined gene therapy via VEGF and mini-dystrophin synergistically improves pathologies in temporalis muscle of dystrophin/utrophin double knockout mice.

DMD UTRN

1.56e-06244233987645
Pubmed

Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.

DMD UTRN

1.56e-06244211297940
Pubmed

Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice.

DMD UTRN

1.56e-06244229408646
Pubmed

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.

DMD UTRN

1.56e-06244222388933
Pubmed

Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.

DMD UTRN

1.56e-06244225642938
Pubmed

Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice.

DMD UTRN

1.56e-06244225859011
Pubmed

ATM-mediated Mad1 Serine 214 phosphorylation regulates Mad1 dimerization and the spindle assembly checkpoint.

ATM MAD1L1

1.56e-06244224728176
Pubmed

Satellite cells and utrophin are not directly correlated with the degree of skeletal muscle damage in mdx mice.

DMD UTRN

1.56e-06244215703201
Pubmed

Microtubule binding distinguishes dystrophin from utrophin.

DMD UTRN

1.56e-06244224706788
Pubmed

Utrophin suppresses low frequency oscillations and coupled gating of mechanosensitive ion channels in dystrophic skeletal muscle.

DMD UTRN

1.56e-06244225941878
Pubmed

Duchenne muscular dystrophy and the neuromuscular junction: the utrophin link.

DMD UTRN

1.56e-0624429297964
Pubmed

Dystrophin and utrophin do not play crucial roles in nonmuscle tissues in mice.

DMD UTRN

1.56e-06244210204788
Pubmed

SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.

DMD UTRN

1.56e-06244225652448
Pubmed

Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis.

DMD UTRN

1.56e-06244228785010
Pubmed

The role of proteases in excitation-contraction coupling failure in muscular dystrophy.

DMD UTRN

1.56e-06244225298424
Pubmed

Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.

DMD UTRN

1.56e-06244216307000
Pubmed

Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice.

DMD UTRN

1.56e-06244221949353
Pubmed

Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.

DMD UTRN

1.56e-06244223097179
Pubmed

rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.

DMD UTRN

1.56e-06244216819550
Pubmed

The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain.

DMD UTRN

1.56e-06244215501597
Pubmed

Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.

DMD UTRN

1.56e-06244211257121
Pubmed

Characterization of dystrophin and utrophin diversity in the mouse.

DMD UTRN

1.56e-06244210072426
Pubmed

The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin.

DMD UTRN

1.56e-0624429625743
Pubmed

Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.

DMD UTRN

1.56e-06244218973234
Pubmed

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.

DMD UTRN

1.56e-06244212387876
Pubmed

Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles.

DMD UTRN

1.56e-06244227881412
Pubmed

Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.

DMD UTRN

1.56e-06244220625423
Pubmed

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.

DMD UTRN

1.56e-06244229065908
Pubmed

Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.

DMD UTRN

1.56e-06244231039133
Pubmed

Developmentally regulated expression and localization of dystrophin and utrophin in the human fetal brain.

DMD UTRN

1.56e-06244211796130
Pubmed

Dystrophin and dystrophin-related protein in the brains of normal and mdx mice.

DMD UTRN

1.56e-0624428159184
Pubmed

Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.

DMD UTRN

1.56e-06244210679963
Pubmed

TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.

DMD UTRN

1.56e-06244221565990
Pubmed

Generation and characterization of transgenic mice with the full-length human DMD gene.

DMD UTRN

1.56e-06244218083704
Pubmed

Expression of the dystrophin-related protein (utrophin) gene during mouse embryogenesis.

DMD UTRN

1.56e-0624428130373
Pubmed

Early Inflammation in Muscular Dystrophy Differs between Limb and Respiratory Muscles and Increases with Dystrophic Severity.

DMD UTRN

1.56e-06244233497702
Pubmed

Dystrophin and dystrophin-related protein (utrophin) distribution in normal and dystrophin-deficient skeletal muscles.

DMD UTRN

1.56e-0624428186702
Pubmed

ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice.

DMD UTRN

1.56e-06244228334037
Pubmed

Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

DMD UTRN

1.56e-06244225940966
Pubmed

Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature.

DMD UTRN

1.56e-06244212868498
Pubmed

Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.

DMD UTRN

1.56e-06244222266080
Pubmed

Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism.

DMD UTRN

1.56e-06244217300937
Pubmed

Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.

DMD UTRN

1.56e-06244221768542
InteractionARRDC3 interactions

PDXDC1 RBM15 DMD SPEN UTRN THRAP3

6.62e-06224426int:ARRDC3
Cytoband16p12.2

NPIPB3 NPIPB4 NPIPB5

6.68e-063745316p12.2
CytobandEnsembl 112 genes in cytogenetic band chr16p12

NPIPB3 NPIPB4 NPIPB5

6.53e-04172453chr16p12
Cytoband16p11.2

NPIPB13 NPIPB12 NPIPB11

8.84e-0419145316p11.2
CytobandEnsembl 112 genes in cytogenetic band chr16p11

NPIPB13 NPIPB12 NPIPB11

2.58e-03278453chr16p11
CytobandEnsembl 112 genes in cytogenetic band chr6q24

REPS1 UTRN

2.69e-0378452chr6q24
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

DMD UTRN

1.26e-041817291
GeneFamilyAAA ATPases

PSMC4 IQCA1

1.11e-0353172413
GeneFamilyRNA binding motif containing

RBM15 SPEN

1.67e-02213172725
CoexpressionJINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP

NPIPB3 RBM15 NPIPB13 NPIPB12 NPIPB11 INKA2 RTTN

3.60e-06380457M38974
CoexpressionJINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN

SPIRE1 NPIPB3 RBM15 NPIPB13 NPIPB12 NPIPB11

1.24e-05302456M38975
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ATM NPIPB4 NPIPB5 UTRN RTTN SMG6

4.90e-08199456f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCelldroplet-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FHAD1 ERICH3 SPATA17 IQCA1 ITPKA

1.32e-06189455fe958fdf9963c2dfe270f67f0da36b3264d0017c
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue

PDXDC1 ATM NPIPB4 SMG6

1.85e-051564541545169694f686d28648a68b552c2ae606599d66
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9

MLXIPL RBM15 SPEN THRAP3

2.15e-05162454810881210e015c788814e4fe8d7a24c929cf2621
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 ERICH3 SPATA17 IQCA1

2.60e-05170454b535baeb4dbd644051cf992babb61add9eaae4e3
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 ERICH3 SPATA17 IQCA1

2.60e-051704542477c9f29dbe27f172df699003971e828d6ab8c9
ToppCellPND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass

FHAD1 ERICH3 SPATA17 IQCA1

2.84e-05174454f41d05a3703d7092bd3c4a97c15ae13069aaa4ad
ToppCellPND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass

FHAD1 ERICH3 SPATA17 IQCA1

2.91e-05175454c01a15b2084da4a18f8ff3623f44eb9dfe499f10
ToppCellfacs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 ERICH3 SPATA17 IQCA1

2.97e-05176454ed788a5969edfd1199828ca5b0dd34e7f29c4d30
ToppCellMid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NPIPB3 DMD NPIPB5 IQCA1

3.11e-05178454ad187db4c40b9078d54dd915c143e0172b2f47b8
ToppCellfacs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FHAD1 ERICH3 SPATA17 IQCA1

3.18e-05179454d4efbc34f52136039b96451fd0b0a0ad164197c6
ToppCellfacs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FHAD1 ERICH3 SPATA17 IQCA1

3.18e-051794548a66d197a2f55d763ff7ef0bec89ee96f59c3937
ToppCelldroplet-Lung-LUNG-30m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 ERICH3 IQCA1 ITPKA

3.46e-051834543991830726d05cf19606d540de04093985b7bdeb
ToppCelldroplet-Lung-LUNG-30m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 ERICH3 IQCA1 ITPKA

3.46e-05183454cc844f54c7564bf432b179ca63bc7c4b9b8cfdd9
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MLXIPL FAT1 NPIPB11 EIF2B4

3.46e-05183454bbf27d2f4369031fadacacd6c432c06b1ec5abdb
ToppCellP07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FHAD1 ERICH3 IQCA1 ITPKA

3.54e-05184454a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2
ToppCellP07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FHAD1 ERICH3 IQCA1 ITPKA

3.54e-05184454ab469b9e06212462cbe2e4db8775c6778db855e6
ToppCellP28-Epithelial-airway_epithelial_cell-club_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FHAD1 SPATA17 IQCA1 ITPKA

3.69e-05186454a26811481668fa25c48a064a56c198685693ad8d
ToppCellP28-Epithelial-airway_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FHAD1 SPATA17 IQCA1 ITPKA

3.69e-05186454df80f101954b8ec6ccdb03e702de22e70b65181f
ToppCellNS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FHAD1 ERICH3 SPATA17 IQCA1

3.69e-0518645476033438426d8f9c72cd6691a7baf92104c9f03d
ToppCellfacs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 ERICH3 IQCA1 ITPKA

3.77e-0518745404dba2ed09ee4180830bdf0191921696697ea234
ToppCellfacs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 ERICH3 IQCA1 ITPKA

3.77e-05187454805dafe22f835ece4dd091d8030d0a63b52a48dd
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

NPIPB4 SPEN UTRN SMG6

3.85e-05188454ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCelldroplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ERICH3 SPATA17 IQCA1 ITPKA

3.85e-051884540eca3dc93724e23b71e687fc24fa9f1e89bdef6a
ToppCelldroplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ERICH3 SPATA17 IQCA1 ITPKA

3.85e-051884549ce3e1fffce87ad19812ecbf9b7f9935a975d676
ToppCellfacs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FHAD1 SPATA17 IQCA1 ITPKA

4.01e-051904549ffd18ef358f8e32c610ab6420f479067c8ba44b
ToppCellfacs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FHAD1 SPATA17 IQCA1 ITPKA

4.01e-051904543ef39d61c98de4e5df946b995847aa65eba6a4b6
ToppCellTransplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

FHAD1 ERICH3 SPATA17 IQCA1

4.01e-05190454a90a38fccdbf75a286b4d258fc54920c02b282f7
ToppCellASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

FHAD1 ERICH3 SPATA17 IQCA1

4.09e-051914540c4b926a28bc94f3cf4d68a911c0a189f6ff505e
ToppCellASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

FHAD1 ERICH3 SPATA17 IQCA1

4.26e-05193454c0d10075862ac878aa05fc49c8b73e470783bf16
ToppCellnucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NPIPB3 NPIPB4 NPIPB5 UTRN

4.26e-05193454779276e775cb2492e8dd36436295a536084a6415
ToppCellnucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NPIPB3 KIF5C NPIPB4 NPIPB5

4.26e-051934549c9434a3297b85774b4f0ecab6294f44d738e29f
ToppCellASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

FHAD1 ERICH3 SPATA17 IQCA1

4.26e-05193454a0baa8be6f590b2031fede22be588715ae458e93
ToppCellIPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

FHAD1 ERICH3 SPATA17 DMD

4.26e-05193454ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCellsevere-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ATM NPIPB4 NPIPB5 UTRN

4.26e-051934549337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCellASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

FHAD1 ERICH3 SPATA17 IQCA1

4.35e-051944545aeb44657ab6f61b1abf98af28d3397d8e44c1aa
ToppCellASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

FHAD1 ERICH3 SPATA17 IQCA1

4.35e-05194454c84a7fa94fb06e08aae04db56c8c313b0afde1d7
ToppCellmoderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

FHAD1 ERICH3 SPATA17 IQCA1

4.44e-05195454e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCellBL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FHAD1 ERICH3 SPATA17 IQCA1

4.44e-0519545407a6bcef6af93ed87df455dee624037cb75e011a
ToppCellcritical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

FHAD1 ERICH3 SPATA17 IQCA1

4.53e-0519645427b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ATM NPIPB4 NPIPB5 UTRN

4.62e-0519745457ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCellmild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ATM NPIPB5 UTRN RTTN

4.62e-05197454e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCellNS-critical-d_0-4-Epithelial-Ciliated-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FHAD1 ERICH3 SPATA17 IQCA1

4.62e-0519745462e20ef825b92908d7732aa625dcff7b95ef6ca8
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

SMARCA4 SH2D4A IQCA1 UTRN

4.62e-051974543d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCellLPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

FHAD1 ERICH3 SPATA17 KIF5C

4.80e-0519945415f7814b7074170eee7ccacaa670b1d128fc68bb
ToppCellParenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

FHAD1 ERICH3 SPATA17 IQCA1

4.89e-052004549c9d2b0276c7b0709c2eeeb0673a2f58106fb14e
ToppCellParenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

FHAD1 ERICH3 SPATA17 IQCA1

4.89e-052004545abd6d81e1cc354484ae693fcd708d78926e75b5
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

SMARCA4 SH2D4A IQCA1 UTRN

4.89e-052004548683445ad5b70748c4a1f12eb77d47623085147e
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MLXIPL ATM NPIPB4

4.65e-041504536c39e73a0b05d4b26589f333ce13924e3d373b8d
ToppCellPND01-03-samps-Epithelial-Epithelial-non_alveolar|PND01-03-samps / Age Group, Lineage, Cell class and subclass

FHAD1 ERICH3 SPATA17

4.93e-04153453fc0d2d50aa3b6b2772bbf3626c9df5c5e8d7d11e
ToppCellPND01-03-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND01-03-samps / Age Group, Lineage, Cell class and subclass

FHAD1 ERICH3 SPATA17

4.93e-041534532482247d9c39c7b99bb45fb9153442f64fd6012f
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPIRE1 KIF5C IQCA1

5.02e-04154453e94cd11488003347120eacd3ced0a8923ed09ccc
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Batf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

UTRN INKA2 ITPKA

5.31e-04157453921805932f7974d37aed547861d555b07f30aba6
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SH2D4A INKA2 ITPKA

5.51e-04159453a082e770fa757c4a1d3ed13d53f83297e36faf05
ToppCell356C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

FHAD1 MLXIPL DMD

5.72e-041614538ec923c230a7a3cce5edf2a736b3a00d607c698a
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

SPIRE1 NPIPB3 CAGE1

5.82e-04162453ca30d9bf61f4133566fdc91c7996e130ea554d01
ToppCell343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

HIVEP3 CAGE1 SH2D4A

5.92e-041634530ab043b68e8739adcedda01165a3758cd0d22728
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

RBM15 FAT1 CHD1L

6.03e-041644534ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0
ToppCell3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RBM15 JAKMIP3 NPIPB11

6.14e-0416545301c6355177d79b4523c8b20366e20b2b62c6d08d
ToppCell5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MLXIPL ERICH3 KIF5C

6.14e-041654534b4e75ad0eb0a6b00c30a000ec6267e23ba2e496
ToppCelllung-Ciliated_Epithelia|lung / shred on tissue and cell subclass

FHAD1 ERICH3 SPATA17

6.36e-0416745326cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L5_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FHAD1 INKA2 ITPKA

6.36e-04167453f1ce6e64ebede1f3ef36fe982f46919fd1f814dd
ToppCell3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MLXIPL ERICH3 KIF5C

6.47e-041684530f736d58cb0ff042fa3ce58e36bde37b6976f8fc
ToppCell15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class

FHAD1 ERICH3 SPATA17

6.58e-04169453425d89ab69e9f9eb3df84056676423e390cc6ab1
ToppCellcontrol-Epithelial-Ciliated-diff|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

FHAD1 ERICH3 SPATA17

6.69e-04170453334c4103eb6e021766f5638a4ab14b59ad085ac7
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

IQCA1 INKA2 ITPKA

6.81e-04171453d07e2c5f7d7f12c68860d4161d76372de174f1d8
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

ATM NPIPB4 UTRN

6.81e-041714532e9a20f8980b78325c52065a9c14ab3656267c05
ToppCellCiliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

FHAD1 ERICH3 IQCA1

6.92e-04172453187ae91148d293537afc77e10da2b64302322224
ToppCellE15.5-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

KIF5C CDH10 INKA2

6.92e-04172453a8b33d8ebc56e442a2ad6ac7dafd0c887571bd95
ToppCelldroplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 SPATA17 IQCA1

7.04e-04173453a40a52d8041d45dc3bef74fe55945ae07aa018d6
ToppCelldroplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 SPATA17 IQCA1

7.04e-04173453f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5
ToppCelldroplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 SPATA17 IQCA1

7.04e-04173453f3f67531f72d6d52e19c7f1f2db1ab4026fb70da
ToppCellCV-Severe-7|CV / Virus stimulation, Condition and Cluster

TXNDC16 NPIPB3 NPIPB5

7.40e-041764533de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCellfacs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FHAD1 ERICH3 IQCA1

7.52e-041774533cfde67b93f3986312f5e74e42504214d966e7dc
ToppCellCV-Severe-7|Severe / Virus stimulation, Condition and Cluster

TXNDC16 NPIPB3 NPIPB5

7.52e-0417745382fdd6185b368f54f03de389427cbe3071d21a99
ToppCellfacs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FHAD1 ERICH3 IQCA1

7.52e-0417745312a52a12a87a31e501ced611f46a90d172ca7e35
ToppCellFetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FHAD1 ERICH3 SPATA17

7.65e-04178453de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCellfacs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 ERICH3 IQCA1

7.90e-04180453cf6e9f757afeb342c5023f6e6152a1b4d0d164b4
ToppCellP03-Epithelial-airway_epithelial_cell-club_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FHAD1 IQCA1 ITPKA

8.02e-0418145360a91587c59029a34e7bec1255083337fe21b72a
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FAT1 SPATA17 IQCA1

8.02e-041814536956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCellFetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FHAD1 ERICH3 SPATA17

8.02e-04181453dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCellP03-Epithelial-airway_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FHAD1 IQCA1 ITPKA

8.02e-041814531ea21d860d4d7abab3e21e130a16d044006656ee
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

IQCA1 UTRN ITPKA

8.02e-0418145357994ff4ecffb15653aee00644d9f887f5e3461d
ToppCellControl-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations)

FHAD1 ERICH3 SPATA17

8.15e-04182453fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 SPATA17 IQCA1

8.28e-0418345318040d0653286071df959513c63d94b555a5d00a
ToppCellfacs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAT1 INKA2 RTTN

8.28e-041834530e8fb371d8eac777451c76f41d53577f5dfb740d
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 SPATA17 IQCA1

8.28e-041834536ca7c2d7c56e0f1b9038ba677b4c1c3dfd63bfce
ToppCellfacs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAT1 INKA2 RTTN

8.28e-04183453cbc3b00faa7e4e0dbbbc8ee105467c65241c7470
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FHAD1 FAT1 DMD

8.42e-04184453102b6f621a5b551e622f97b12d787c080b052a72
ToppCellfacs-Lung-EPCAM-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 IQCA1 ITPKA

8.42e-04184453afb11ab301ef9801333dbb53ccff4bd0d44f1677
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FHAD1 FAT1 DMD

8.42e-04184453689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCellfacs-Lung-EPCAM-24m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FHAD1 IQCA1 ITPKA

8.42e-04184453a411c0bcb283534a1c15f22473c46b7d87e01294
ToppCellFetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FHAD1 ERICH3 SPATA17

8.55e-041854533e39a3cb534dfe2301930f3e2f7e8cefb522c158
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPIRE1 DMD UTRN

8.55e-04185453eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCellNS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FHAD1 ERICH3 SPATA17

8.55e-041854535e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MLXIPL FAT1 IQCA1

8.68e-04186453f28d72b47624b69a580b4429e2be560a26898591
ToppCellNS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FHAD1 ERICH3 SPATA17

8.68e-0418645385787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells)

FHAD1 ERICH3 SPATA17

8.68e-04186453708c5edefe36c91df27cf53c1b5101fb2030cc5a
ToppCell390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells)

FHAD1 ERICH3 SPATA17

8.68e-04186453029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b
ToppCelldroplet-Lung-nan-18m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ERICH3 SPATA17 IQCA1

8.68e-04186453740fd06bcd3b24e6ff2ecf8080f378afc3e95084
DiseaseHereditary Non-Polyposis Colon Cancer Type 2

SMARCA4 MSH3 ATM

2.38e-0619413C1333991
DiseaseColorectal cancer, hereditary nonpolyposis, type 1

SMARCA4 MSH3 ATM

2.38e-0619413C2936783
DiseaseHereditary Nonpolyposis Colorectal Neoplasms

SMARCA4 MSH3 ATM

6.33e-0626413C0009405
DiseaseHereditary non-polyposis colorectal cancer syndrome

SMARCA4 MSH3 ATM

7.12e-0627413C1112155
DiseaseHereditary Nonpolyposis Colorectal Cancer

SMARCA4 MSH3 ATM

8.87e-0629413C1333990
Diseasefree cholesterol to total lipids in very small VLDL percentage

PDXDC1 SMARCA4 MLXIPL

2.96e-0543413EFO_0022290
Diseaselung non-small cell carcinoma (is_implicated_in)

SMARCA4 FAT1 MSH3 ATM

4.17e-05139414DOID:3908 (is_implicated_in)
Diseasetriglycerides to total lipids in medium LDL percentage

PDXDC1 SMARCA4 MLXIPL

4.66e-0550413EFO_0022334
Diseasetriglycerides to total lipids in large LDL percentage

PDXDC1 SMARCA4 MLXIPL

4.95e-0551413EFO_0022331
Diseasetriglycerides to total lipids in very large VLDL percentage

PDXDC1 SMARCA4 MLXIPL

5.56e-0553413EFO_0022340
Diseasecholesterol to total lipids in very large VLDL percentage

PDXDC1 SMARCA4 MLXIPL

5.88e-0554413EFO_0022244
Diseasecholesterol to total lipids in large LDL percentage

PDXDC1 SMARCA4 MLXIPL

6.56e-0556413EFO_0022235
Diseasefree cholesterol to total lipids in large HDL percentage

PDXDC1 SMARCA4 MLXIPL

6.56e-0556413EFO_0022279
Diseasecholesteryl esters to total lipids in large VLDL percentage

PDXDC1 SMARCA4 MLXIPL

6.56e-0556413EFO_0022250
Diseasefree cholesterol to total lipids in medium VLDL percentage

PDXDC1 SMARCA4 MLXIPL

6.92e-0557413EFO_0022284
Diseasetriglycerides to total lipids in small VLDL percentage

PDXDC1 SMARCA4 MLXIPL

7.29e-0558413EFO_0022338
Diseasecholesterol in IDL measurement

PDXDC1 SMARCA4 MLXIPL

7.29e-0558413EFO_0021899
Diseasefree cholesterol to total lipids in very large VLDL percentage

PDXDC1 SMARCA4 MLXIPL

7.67e-0559413EFO_0022289
Diseasefree cholesterol in IDL measurement

PDXDC1 SMARCA4 MLXIPL

8.47e-0561413EFO_0022181
Diseasefree cholesterol in very large HDL measurement

PDXDC1 SMARCA4 MLXIPL

8.90e-0562413EFO_0022273
Diseasetriglycerides to total lipids in medium VLDL percentage

PDXDC1 SMARCA4 MLXIPL

9.33e-0563413EFO_0022335
Diseasecholesterol to total lipids in medium VLDL percentage

PDXDC1 SMARCA4 MLXIPL

9.33e-0563413EFO_0022239
Diseasefatty acid measurement, linoleic acid measurement

PDXDC1 SMARCA4 MLXIPL

1.17e-0468413EFO_0005110, EFO_0006807
Diseasetriglycerides to total lipids in very small VLDL percentage

PDXDC1 SMARCA4 MLXIPL

1.22e-0469413EFO_0022341
Diseasemetabolite measurement, diet measurement

PDXDC1 SMARCA4 PDXDC2P

1.33e-0471413EFO_0004725, EFO_0008111
Diseasefree cholesterol to total lipids in small VLDL percentage

PDXDC1 SMARCA4 MLXIPL

1.57e-0475413EFO_0022287
Diseasefree cholesterol:total lipids ratio, intermediate density lipoprotein measurement

PDXDC1 SMARCA4 MLXIPL

2.35e-0486413EFO_0008595, EFO_0020945
DiseaseAdenocarcinoma of prostate

ATM MAD1L1

3.52e-0420412C0007112
Diseasemuscular dystrophy (implicated_via_orthology)

DMD UTRN

3.89e-0421412DOID:9884 (implicated_via_orthology)
DiseaseHeadache, type 2 diabetes mellitus

INKA2 MAD1L1

4.68e-0423412HP_0002315, MONDO_0005148
DiseaseR-6-hydroxywarfarin measurement

FHAD1 RBM15 SPEN

5.38e-04114413EFO_0803327
Diseaseomega-3 polyunsaturated fatty acid measurement

PDXDC1 SMARCA4 MLXIPL

5.95e-04118413EFO_0010119
Diseasecholesterol:total lipids ratio, intermediate density lipoprotein measurement

PDXDC1 SMARCA4 MLXIPL

6.40e-04121413EFO_0008595, EFO_0020943
Diseasecholesterol to total lipids in medium LDL percentage

PDXDC1 SMARCA4

6.47e-0427412EFO_0022238
Diseaselung small cell carcinoma (is_implicated_in)

FAT1 ATM

6.96e-0428412DOID:5409 (is_implicated_in)
Diseasetriglycerides:total lipids ratio, intermediate density lipoprotein measurement

PDXDC1 SMARCA4 MLXIPL

7.37e-04127413EFO_0008595, EFO_0020947
Diseasedocosahexaenoic acid measurement

PDXDC1 SMARCA4 MLXIPL

7.37e-04127413EFO_0007761
Diseaselevel of Sphingomyelin (d42:2) in blood serum

SMARCA4 MLXIPL

7.47e-0429412OBA_2045183
Diseasepolyunsaturated fatty acid measurement

PDXDC1 SMARCA4 MLXIPL

8.06e-04131413EFO_0010733
Diseasetelomere length

HIVEP3 ATM SH2D4A MAD1L1

9.23e-04313414EFO_0004505
Diseasephospholipid measurement

PDXDC1 SMARCA4 MLXIPL

9.77e-04140413EFO_0004639
Diseasechylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio

SMARCA4 SPATA17

1.03e-0334412EFO_0008317, EFO_0008596, EFO_0020944
Diseasecholesterol:total lipids ratio, low density lipoprotein cholesterol measurement

PDXDC1 SMARCA4 MLXIPL

1.06e-03144413EFO_0004611, EFO_0020943
Diseaseendometrial cancer (is_implicated_in)

MSH3 ATM

1.15e-0336412DOID:1380 (is_implicated_in)
DiseaseDuchenne muscular dystrophy (implicated_via_orthology)

DMD UTRN

1.15e-0336412DOID:11723 (implicated_via_orthology)
Diseasetriglycerides:total lipids ratio, low density lipoprotein cholesterol measurement

PDXDC1 SMARCA4 MLXIPL

1.19e-03150413EFO_0004611, EFO_0020947
Disease5-HIAA measurement

THRAP3 SMG6

1.35e-0339412EFO_0005132

Protein segments in the cluster

PeptideGeneStartEntry
KEARPRKDNRRPDLE

SMG6

36

Q86US8
RKEILPKELDLARER

ERICH3

1046

Q5RHP9
DPKDHEKENLRRIRE

ENKD1

96

Q9H0I2
ERNKHLEDLIRKPRE

CAGE1

731

Q8TC20
PRDERKIKEIDRELQ

DMD

1906

P11532
LKLAVDRERERPVKA

IQCA1

451

Q86XH1
EPSRKPKRRRAADVE

NPIPB3

966

Q92617
RLDQPKLDEVTRRIK

RBM15

836

Q96T37
LEPYLKEVIRERKER

UQCRB

91

P14927
DVEPSRKPKRRRAAD

NPIPB12

871

F8W0I5
KIRLPEREKPDRERN

FAT1

1251

Q14517
TEIDRRKKRPLENDG

MSH3

81

P20585
KSELVRLPRLERELK

MAD1L1

246

Q9Y6D9
RSVRPDRDRLLKEKP

INKA2

216

Q9NTI7
LEKLIKDDIERGRLP

PDXDC1

221

Q6P996
LEKLIKDDIERGRLP

PDXDC2P

221

Q6P474
RILELEERERKSPAI

JAKMIP3

611

Q5VZ66
DVEPSRKPKRRRAAD

NPIPB5

1076

A8MRT5
DVEPSRKPKRRRAAD

NPIPB4

1081

C9JG80
DDLLLRRLVKKPERQ

EIF2B4

151

Q9UI10
LEEELTKARERPKLR

ITPKA

271

P23677
EPSRKPKRRRAADVE

NPIPB11

1106

E5RHQ5
KRLIRDPETIKHLDR

ATM

31

Q13315
ELRARIKELEKARSP

FHAD1

1156

B1AJZ9
RNPAAIEEKKLRRDI

CDH10

676

Q9Y6N8
RKRVLSPEELEDRQK

CHD1L

631

Q86WJ1
DVEPSRKPKRRRAAD

NPIPB13

1081

A6NJU9
RKEGLRLAEDRSKDP

IRF3

86

Q14653
KKPIELRLDDRRELV

RTTN

811

Q86VV8
EPIDELKLAREELRR

SPATA17

266

Q96L03
LKALEKEQRERIPRA

UTRN

731

P46939
KPVRRRLKSEDELRP

REPS1

701

Q96D71
RLDRKIEFPLPDRRQ

PSMC4

326

P43686
ELPKLEKRLRATAER

KIF5C

861

O60282
LDRRREEARNPKRKP

SMARCA4

1321

P51532
RLRKPSREDDLLAPK

MLXIPL

191

Q9NP71
RRIVDPRERVKEDDL

EIF4ENIF1

96

Q9NRA8
EPEKKRRRIEELLAE

UBA3

6

Q8TBC4
FRDRKRKLPLELTVE

TXNDC16

381

Q9P2K2
KDDPVDLRLDIERRK

THRAP3

711

Q9Y2W1
REGEAERKPVRKEIL

SPEN

1031

Q96T58
ERILEEIKAERKLRP

SPIRE1

371

Q08AE8
PLRKRRKEKSLGDEE

HIVEP3

711

Q5T1R4
RARLKAEQEAEEPRK

SH2D4A

101

Q9H788
EAEKRPYIDEAKRLR

SOX14

51

O95416